Nixon's Schedule I Was Based on Science

The claim

The popular story is straightforward: in 1970, cannabis was placed in Schedule I of the Controlled Substances Act because scientists and medical experts reviewed the evidence and concluded it had high abuse potential and no accepted medical use. This framing appears in congressional hearings, advocacy materials, and mainstream media. The implication is clear—the schedule reflects pharmacology, not politics, and that rescheduling would mean government scientists overriding their own findings.

This narrative is wrong in nearly every particular. The placement was explicitly temporary, the scientific commission that reviewed the evidence recommended the opposite outcome, and the decision to keep cannabis in Schedule I was made by the President personally, against the advice of his own commission, for reasons documented on tape and having nothing to do with pharmacology.

What actually happened in 1970

The Controlled Substances Act was signed into law on October 27, 1970. During drafting, Assistant Secretary of Health Roger Egeberg submitted a letter to Congress on August 14, 1970, recommending that cannabis be placed in Schedule I. Crucially, Egeberg's letter explicitly framed this as a holding position. He wrote: "Since there is still a considerable void in our knowledge of the plant and effects of the active drug contained in it, our recommendation is that marihuana be retained within Schedule I at least until the completion of certain studies now underway." Strong evidence

The studies he referred to were to be conducted by a newly created National Commission on Marihuana and Drug Abuse. Nixon appointed former Pennsylvania Governor Raymond P. Shafer as chair and filled the commission with conservatives, expecting a report that would justify strict prohibition ^[1]. Instead, after two years of evidence review, the Shafer Commission published Marihuana: A Signal of Misunderstanding in March 1972.

The commission's central finding: cannabis did not justify criminal penalties then in place. Its main recommendation was decriminalization of personal possession and non-profit transfers of small amounts Strong evidence. The report explicitly rejected the idea that cannabis caused violence, inevitably led to harder drugs, or represented a public health emergency warranting incarceration.

Nixon's rejection: what the tapes reveal

Nixon rejected the Shafer Commission's findings before they were published. Declassified White House tape transcripts show the President discussing cannabis policy in language divorced entirely from pharmacology or public health ^[2][3].

In a May 1971 recorded conversation with Chief of Staff Bob Haldeman, Nixon explicitly links marijuana to ethnic and political enemies, stating: "Every one of the bastards that are out for legalizing marijuana is Jewish" Strong evidence^[2]. He instructs Haldeman to ensure the coming commission report supports his existing position regardless of the actual evidence.

In a recorded Oval Office meeting with Shafer on September 9, 1971, Nixon tells the commission chairman directly that he wants a report backing prohibition—not because the science demanded it, but because Nixon had already decided ^[3]. The tapes make clear the President's concern was cultural and political: linking marijuana to hippies, anti-war activists, and what he perceived as a threat to social order ^[2].

John Ehrlichman, Nixon's domestic policy advisor, later told journalist Dan Baum: "We knew we couldn't make it illegal to be either against the war or black, but by getting the public to associate the hippies with marijuana and blacks with heroin, and then criminalizing both heavily, we could disrupt those communities" Anecdote^[4]. Ehrlichman's family has contested this quote, but the sentiment is consistent with what the declassified tapes show Nixon himself saying on the record.

The 'no accepted medical use' circularity

Schedule I requires that a substance have "no currently accepted medical use in treatment in the United States." Strong evidence This sounds like a scientific finding, but it is actually a regulatory and legal determination hinged on FDA approval—a status historically almost impossible to achieve for a Schedule I drug.

The loop was airtight: researchers needed DEA permission and federally supplied cannabis to conduct trials; those trials were the only path to "accepted medical use"; without "accepted medical use," the substance remained Schedule I; remaining in Schedule I kept the research bottleneck in place Strong evidence^[5]. This circularity has been documented in peer-reviewed neuroscience and medicine for decades and explicitly acknowledged by the U.S. Department of Health and Human Services in its 2024 rescheduling recommendation Strong evidence^[6].

The same government that kept cannabis in Schedule I to prevent "accepted medical use" simultaneously filed and holds U.S. Patent 6,630,507, granted in 2003, claiming cannabinoids as antioxidants and neuroprotectants Strong evidence^[7]. It is logically and legally inconsistent to maintain that a substance has no medical use while the government patents its medical applications.

Where the 'based on science' story comes from

The claim that Schedule I reflects scientific consensus has two main sources, both unreliable.

The first is the DEA itself, which has defended the schedule in court filings and in responses to rescheduling petitions by citing the statutory language as if it were a scientific finding ^[5]. The agency conflates regulatory status with pharmacological evidence, a standard move in drug policy defense but not a truthful one.

The second source is anti-legalization advocacy, which cites the schedule as proof of harm—a circular argument in which the policy decision becomes its own justification. Because cannabis is Schedule I, it must be harmful; therefore, it should stay Schedule I.

The claim persists because most people have never read the Shafer Report or Egeberg's letter, assume a 54-year-old federal classification rests on substantial evidence, and do not know that Nixon tapes were declassified. The story is plausible because it sounds like how law and science should interact—but it is not what happened.

What actually changed: HHS review and rescheduling

In August 2023, the U.S. Department of Health and Human Services formally recommended rescheduling cannabis from Schedule I to Schedule III, the first time a federal health agency has publicly contradicted the 1970 placement on its scientific merits Strong evidence^[6]. The HHS letter explicitly states that cannabis has accepted medical use under modern criteria and that the Schedule I classification no longer reflects the available evidence ^[6].

This recommendation came 51 years after the Shafer Commission reached the same conclusion and 53 years after Nixon overruled it. It does not mean the question of cannabis policy is settled—reasonable people disagree about scheduling, taxation, advertising, and age limits. But those disagreements should begin from the actual history: not from a myth of careful scientific process, but from the documented fact that a political decision in 1970 was defended for half a century by redefining regulatory status as pharmacological evidence.

How to verify this yourself

All primary sources are public and accessible:

• Egeberg's letter to Congress (August 14, 1970): Available in DEA scheduling records and NORML archives.
• Marihuana: A Signal of Misunderstanding (Shafer Commission, March 1972): Published by the U.S. Government Printing Office and archived at the National Criminal Justice Reference Service.
• Nixon tape transcripts: The White House tapes have been declassified and are available through the Nixon Presidential Library and in published compilations ^[2][3].
• HHS rescheduling recommendation (August 2023): Published by the Department of Health and Human Services ^[6].

If someone claims Schedule I is based on science, ask: Which scientific body recommended it? The truthful answer is: none. The Shafer Commission, Nixon's own hand-picked commission, recommended decriminalization. Nixon overruled it. Every administration since has inherited that decision without revisiting the underlying evidence until HHS did so in 2023. That is the history. Everything else is retroactive justification.

Sources

How this page was made

Related

• "Marijuana Was Banned Because of Racism Only" Is Oversimplified — Racism drove U.S. cannabis prohibition, but so did other forces. The enforcement gap is wh...
• Schedule I and Cannabis — Federal classification, its legal consequences, and the ongoing rescheduling debate.